why choose us

First received: April 14, 2023

Clinical Trial: Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ovary Cancer

Study Type: INTERVENTIONAL


Official Title: The Impact of Alternate Day Fasting After Surgery for Patients Undergoing chemoTherapy (FAST Study)

Brief Summary: Endometrial cancer is the most common gynecologic cancer and ovarian cancer is the most lethal.The management of both advanced cancers is a combination of chemotherapy and surgery.Standard of care chemotherapeutic treatment for uterine and ovarian cancers is toxic and severely disruptive to the patient's quality of life with the potential for devastating short and long-term side effects.The role of fasting and ketogenic diets has been evaluated in a mixed cancer population and previously shown to be…

Read more